The proportion of CD86 + MDSCs in the spleen and blood after combination therapy was much higher than that in the tumor-bearing control group, and there was an increasing trend compared to the cryo-thermal therapy group ( Figure 2 E and Figure S3C ).
← all excerpts
Combining Cryo-Thermal Therapy with Anti-IL-6 Treatment Promoted the Maturation of MDSCs to Induce Long-Term Survival in a Mouse Model of Breast Cancer.
1
—
—